HomeWhat is GSHArticlesFAQsGSH & DiseasesContact Us

 

 

 

 

home > articles > parkinson's disease > idiopathic parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients

Glutathione Articles - Parkinson's Disease

Idiopathic Parkinson's Disease, Progressive Supranuclear Palsy and Glutathione Metabolism in the Substantia Nigra of Patients
Perry TL and Yong VW
Neurosci Lett. 1986 Jun 30;67(3):269-74.
> download PDF version of this abstract

ABSTRACT

Glutathione transferase activity and total glutathione (GSH) content were measured in several regions of autopsied brain from patients dying with idiopathic Parkinson's disease (P D) or progressive supranuclear palsy (PSP), and from control subjects. A significant deficiency of GSH was found in the substantia nigra, but not in 5 other brain regions of PD patients, nor in PSP patients' brains. Glutathione transferase activity was similar in the substantia nigra of PD, PSP and control patients. Since total GSH is consumed only by conjugation in detoxification processes, nigral GSH deficiency in PD patients implies continued local presence of a possible causative neurotoxin up to the time of death.

> download PDF version of this abstract


If you would like us to send you the full text version of the article listed above, please contact us by phone or e-mail:

Caron Coats

Toll Free:
Tel: 800-227-2627
Fax: 800-369-0302
Local:
Tel: 205-879-6551
Fax: 205-871-2568
Email:
ccoats@wellnesshealth.com

 

     
 


Glutathione Experts | What is Glutathione (GSH)? | Glutathione Articles | GSH FAQs | GSH & Diseases | Contact